Showing results (1631-1640 of 2,131) with videos related to
Sort By:
Pageof 214
Circulation|May 30, 2018
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome StudyMandeep R Mehra, Christopher Salerno, Joseph C Cleveland, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002Eric P Winer, Clifford Hudis, Harold J Burstein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2011
p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905)Jonathan F Lara, Ann D Thor, Lynn G Dressler, et al.JAMA Cardiology|January 16, 2020
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical TrialDaniel J Goldstein, Yoshifumi Naka, Douglas Horstmanshof, et al.NPJ Breast Cancer|May 17, 2023
Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancerYuli Chen, Haojia Li, Andrew Janowczyk, et al.Blood|June 15, 2011
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironmentAsh A Alizadeh, Andrew J Gentles, Alvaro J Alencar, et al.The Journal of Thoracic and Cardiovascular Surgery|June 11, 2021
Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter studyOmar Saeed, Antone J Tatooles, Muhammad Farooq, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2018
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102Noah Kornblum, Fengmin Zhao, Judith Manola, et al.Circulation. Heart Failure|December 12, 2012
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesisLili Yu, Willem P T Ruifrok, Maxi Meissner, et al.The Annals of Thoracic Surgery|April 14, 2019
Hemolysis and Nonhemorrhagic Stroke During Venoarterial Extracorporeal Membrane OxygenationOmar Saeed, William A Jakobleff, Stephen J Forest, et al.Pageof 214